Clinical Trials

100 enrolled

Phase 2 Active not recruiting

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02151084 2025-12-16

A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer

57 enrolled

Gastrointestinal

Gallbladder Neoplasms, Recurrence

NCT03618550 2025-12-02

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

257 enrolled

Phase 2 Active not recruiting

Hodgkin Disease, Recurrence

NCT05498220 2025-09-02

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

5 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT04680988 2025-08-05

A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

194 enrolled

Uterine Cervical Neoplasms, Recurrence

NCT04984837 2025-08-01

Study of Lacutamab in Peripheral T-cell Lymphoma

56 enrolled

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT07001540 2025-06-19

Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous Transplantation

130 enrolled

Phase 2 Not yet recruiting

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT06892431 2025-03-25

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

150 enrolled

Head & Neck

Nasopharyngeal Neoplasms, Recurrence

NCT02203760 2024-11-15

PazoDoble

Phase 2 Active not recruiting

58 enrolled

Sarcoma

Carcinosarcoma, Leiomyosarcoma, Recurrence

NCT04739670 2024-03-01

BELLA

31 enrolled

Breast

Recurrence, Triple Negative Breast Neoplasms

NCT00574496 2023-09-28

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

25 enrolled 10 charts

Hodgkin Disease, Lymphoma, Recurrence

NCT03422523 2022-08-22

ARGO

53 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT01610206 2021-02-25

A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer

148 enrolled 11 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT01200329 2019-12-16

High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease

81 enrolled 8 charts

Hodgkin Disease, Lymphoma, Recurrence

NCT02060656 2019-09-19

LEGEND

92 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02789189 2019-09-06

Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail

60 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT00531687 2017-10-03

Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer

8 enrolled

Genitourinary

Recurrence, Testicular Neoplasms

NCT00312650 2015-01-12

Doxil and Gemcitabine in Recurrent Ovarian Cancer

24 enrolled

Ovarian Neoplasms, Recurrence

NCT02114502 2014-07-11

Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma

Phase 2 Withdrawn

Plasma cell

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT01884441 2014-01-29

Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients

59 enrolled

Hodgkin Disease, Lymphoma, Recurrence

NCT01388621 2013-08-20

PROVE

140 enrolled

Ovarian Neoplasms, Recurrence

NCT00070304 2013-07-26

Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma

33 enrolled

Hodgkin Disease, Lymphoma, Recurrence

NCT00100789 2012-10-01

S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer